Physician profile
Jenna Laskey
NPI 1174974216
$1,014.31
in general payments reported to CMS, 2019-2025
19 companies · $562 in 2025
The $562 reported for 2025 was more than what 76% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.02 · 2020: $50.99 · 2022: $73.34 · 2023: $67.03 · 2024: $234 · 2025: $562.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $863.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $862.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $172.27 | 2020-2025 | |
| Exact Sciences Corporation | $155.64 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Abbvie INC. | $138.21 | 2022-2025 | |
| Glaxosmithkline, LLC. | $88.64 | 2020-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Lilly USA, LLC | $77.69 | 2024-2025 | Mounjaro, Zepbound |
| Gilead Sciences, INC. | $53.51 | 2025 | |
| Novo Nordisk INC | $46.73 | 2019-2025 | Ozempic |
| Abbott Laboratories | $40.66 | 2023-2025 | Freestyle Libre |
| Novartis Pharmaceuticals Corporation | $32.63 | 2023 | |
| Scilex Pharmaceuticals INC. | $30.52 | 2024 | |
| Insulet Corporation | $26.71 | 2025 | Omnipod |
| Dexcom, INC. | $25.55 | 2024 | Dexcom G6 Transmitter |
| Viatris Specialty LLC | $23.15 | 2025 | Yupelri |
| Biohaven Pharmaceutical Holding Company LTD. | $20.72 | 2022 | |
| Tris Pharma INC | $19.69 | 2025 | Dyanavel Xr |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $18.46 | 2024 | Terlivaz |
| Astrazeneca Pharmaceuticals LP | $17.20 | 2025 | Airsupra |
| Otsuka America Pharmaceutical, INC. | $15.29 | 2023 | Abilify Maintena, Rexulti |
| Takeda Pharmaceuticals U.S.A., INC. | $11.04 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenna Laskey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.